Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells

Cited 18 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorB R Yi-
dc.contributor.authorK A Hwang-
dc.contributor.authorN H Kang-
dc.contributor.authorS U Kim-
dc.contributor.authorE B Jeung-
dc.contributor.authorHyoung-Chin Kim-
dc.contributor.authorK C Choi-
dc.date.accessioned2017-04-19T09:33:28Z-
dc.date.available2017-04-19T09:33:28Z-
dc.date.issued2012-
dc.identifier.issn09291903-
dc.identifier.uri10.1038/cgt.2012.45ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/10911-
dc.description.abstractStem cells have received a great deal of attention for their clinical and therapeutic potential for treating human diseases and disorders. Recent studies have shown that it is possible to genetically engineered stem cells (GESTECs) to produce suicide enzymes that convert non-toxic prodrugs to toxic metabolites, selectively migrate toward tumor sites and reduce tumor growth. In this study, we evaluated whether these GESTECs are capable of migrating to hepatocarcinoma cells and examined the potential therapeutic efficacy of gene-directed enzyme prodrug therapy against liver cancer cells in cellular and animal models. A modified transwell migration assay was performed to determine the migratory capacity of GESTECs to Hep3B hepatocarcinoma cells. GESTECs, that is, HB1.F3.CD or HB1.F3.CD.interferon-β (IFN-β) cells, engineered to express a suicide gene, cytosine deaminase (CD), selectively migrated toward liver cancer cells. Treatment of Hep3B, human liver cancer cells, with the prodrug 5-fluorocytosine (5-FC) in the presence of HB1.F3.CD or HB1.F3.CD.IFN-β cells resulted in the inhibition of Hep3B cell growth. In a xenografted mouse model injected with hepatocarcinoma, we investigated the therapeutic effect of these stem cells. For 9 weeks, the xenografted mice were treated with HB1.F3.CD or HB1.F3.CD.IFN-β in the presence of 5-FC. A growth of tumor mass was inhibited about 40-50% in the mice treated with GESTECs and a prodrug. In addition, we further confirmed the cytotoxic effect on tumor cells by histological analysis and migratory effect of therapeutic stem cells. Taken together, GESTECs expressing a fusion gene encoding CD and IFN-β may exert a synergistic antitumor effect on this type of tumor.-
dc.publisherSpringer-Nature Pub Group-
dc.titleSynergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells-
dc.title.alternativeSynergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells-
dc.typeArticle-
dc.citation.titleCancer Gene Therapy-
dc.citation.number9-
dc.citation.endPage651-
dc.citation.startPage644-
dc.citation.volume19-
dc.contributor.affiliatedAuthorHyoung-Chin Kim-
dc.contributor.alternativeName-
dc.contributor.alternativeName-
dc.contributor.alternativeName-
dc.contributor.alternativeName-
dc.contributor.alternativeName-
dc.contributor.alternativeName김형진-
dc.contributor.alternativeName-
dc.identifier.bibliographicCitationCancer Gene Therapy, vol. 19, no. 9, pp. 644-651-
dc.identifier.doi10.1038/cgt.2012.45-
dc.subject.keywordcytosine deaminase-
dc.subject.keywordhepatocarcinoma-
dc.subject.keywordinterferon-beta-
dc.subject.keywordtherapeutic stem cell-
dc.subject.keywordtumor tropism-
dc.subject.localcytosine deaminase-
dc.subject.localhepatocarcinoma-
dc.subject.localinterferon-beta-
dc.subject.localInterferon-beta-
dc.subject.localtherapeutic stem cell-
dc.subject.localtumor tropism-
dc.description.journalClassY-
Appears in Collections:
Ochang Branch Institute > Division of Bioinfrastructure > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.